Product Information
ENDACOF-DM LIQUID is a generic product labeled by Larken Laboratories, Inc., priced at $0.0512 per ML under NDC 68047014316. Its NADAC has been published 671 times since Nov 28, 2013.
ENDACOF-DM LIQUID
Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine HydrochlorideStrength
1; 5; 2.5 mg/5mL; mg/5mL; mg/5mL
Manufacturer
Larken Laboratories, Inc.NDC
68047014316
Classification
Generic
Dosage Form
LIQUID
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
BROMPHENIRAMINE MALEATE; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
3/30/2012
Pharmacological Classes
Price Statistics
The NADAC for ENDACOF-DM LIQUID has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 55.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0512 per ML |
|---|---|
| All-time high | $0.0520 (Aug 12, 2026) |
| All-time low | $0.0328 (Apr 23, 2014) |
| 52-week high | $0.0520 |
| 52-week low | $0.0458 |
| Median price | $0.0388 |
| Average price | $0.0400 |
| Largest weekly change | +30.9% (Aug 17, 2022) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Larken Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Brompheniramine Maleate, Dextromethorphan Hydrobromide and Phenylephrine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Sigma-1 Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ENDACOF-DM LIQUID?
The current National Average Drug Acquisition Cost (NADAC) for ENDACOF-DM LIQUID, manufactured by Larken Laboratories, Inc., is $0.0512 per ML (NDC 68047014316), effective Sep 30, 2026.
How has the price of ENDACOF-DM LIQUID changed over time?
Over the history we have for it, the NADAC for ENDACOF-DM LIQUID has risen 55.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ENDACOF-DM LIQUID?
Since Nov 28, 2013, the NADAC for ENDACOF-DM LIQUID has ranged from a low of $0.0328 (Apr 23, 2014) to a high of $0.0520 (Aug 12, 2026), with a median of $0.0388 per ML.
Are there cheaper alternatives to ENDACOF-DM LIQUID?
No other NADAC-published product currently shares the active ingredient and strength of ENDACOF-DM LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ENDACOF-DM LIQUID?
ENDACOF-DM LIQUID (NDC 68047014316) is labeled by Larken Laboratories, Inc., and CMS classifies it as a generic product.